Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer

Yukiko Murata, Katsunori Tatsugami, Masahiro Yoshikawa, Masumitsu Hamaguchi, Shigetomo Yamada, Yusuke Hayakawa, Kouhei Ueda, Seiya Momosaki, Naotaka Sakamoto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. Methods: A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. Results: The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months. Conclusions: In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.

Original languageEnglish
Pages (from-to)284-289
Number of pages6
JournalInternational Journal of Urology
Volume25
Issue number3
DOIs
Publication statusPublished - Mar 2018

Fingerprint

Prostatectomy
Prostatic Neoplasms
Recurrence
Carcinoma, Intraductal, Noninfiltrating
Survival Rate
Prostate
Survival
Neoplasm Grading
Seminal Vesicles
Prostate-Specific Antigen

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer. / Murata, Yukiko; Tatsugami, Katsunori; Yoshikawa, Masahiro; Hamaguchi, Masumitsu; Yamada, Shigetomo; Hayakawa, Yusuke; Ueda, Kouhei; Momosaki, Seiya; Sakamoto, Naotaka.

In: International Journal of Urology, Vol. 25, No. 3, 03.2018, p. 284-289.

Research output: Contribution to journalArticle

Murata, Y, Tatsugami, K, Yoshikawa, M, Hamaguchi, M, Yamada, S, Hayakawa, Y, Ueda, K, Momosaki, S & Sakamoto, N 2018, 'Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer', International Journal of Urology, vol. 25, no. 3, pp. 284-289. https://doi.org/10.1111/iju.13514
Murata, Yukiko ; Tatsugami, Katsunori ; Yoshikawa, Masahiro ; Hamaguchi, Masumitsu ; Yamada, Shigetomo ; Hayakawa, Yusuke ; Ueda, Kouhei ; Momosaki, Seiya ; Sakamoto, Naotaka. / Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer. In: International Journal of Urology. 2018 ; Vol. 25, No. 3. pp. 284-289.
@article{78379392a35141cbb471f357327ab1e5,
title = "Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer",
abstract = "Objective: To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. Methods: A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. Results: The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6{\%}. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9{\%}, 70.7{\%}, 38.3{\%} and 28.8{\%}, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1{\%} after 18 months. Conclusions: In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.",
author = "Yukiko Murata and Katsunori Tatsugami and Masahiro Yoshikawa and Masumitsu Hamaguchi and Shigetomo Yamada and Yusuke Hayakawa and Kouhei Ueda and Seiya Momosaki and Naotaka Sakamoto",
year = "2018",
month = "3",
doi = "10.1111/iju.13514",
language = "English",
volume = "25",
pages = "284--289",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer

AU - Murata, Yukiko

AU - Tatsugami, Katsunori

AU - Yoshikawa, Masahiro

AU - Hamaguchi, Masumitsu

AU - Yamada, Shigetomo

AU - Hayakawa, Yusuke

AU - Ueda, Kouhei

AU - Momosaki, Seiya

AU - Sakamoto, Naotaka

PY - 2018/3

Y1 - 2018/3

N2 - Objective: To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. Methods: A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. Results: The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months. Conclusions: In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.

AB - Objective: To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. Methods: A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. Results: The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months. Conclusions: In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.

UR - http://www.scopus.com/inward/record.url?scp=85044255956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044255956&partnerID=8YFLogxK

U2 - 10.1111/iju.13514

DO - 10.1111/iju.13514

M3 - Article

C2 - 29315854

AN - SCOPUS:85044255956

VL - 25

SP - 284

EP - 289

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 3

ER -